Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,988 | 42,634 | 13,855 | 17,025 | 19,246 |
| Marketable Securities | 22 | 49 | 101 | 126 | 135 |
| Receivables | 2,834 | 1,298 | N/A | N/A | N/A |
| Other current assets | 2,467 | 3,552 | 0 | 0 | 0 |
| TOTAL | $45,399 | $48,986 | $14,561 | $17,891 | $20,476 |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 7 | 8 | 9 |
| TOTAL | $5 | $6 | $7 | $8 | $9 |
| Total Assets | $45,404 | $48,992 | $14,568 | $17,899 | $20,485 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 215 |
| Accounts payable and accrued liabilities | 2,221 | 1,069 | 1,468 | 1,886 | 1,579 |
| Accrued Expenses | 1,933 | 1,684 | 1,223 | 1,418 | 1,419 |
| TOTAL | $4,154 | $2,753 | $2,691 | $3,304 | $3,213 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,154 | $2,753 | $2,691 | $3,304 | $3,213 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,952 | 20,948 | 20,807 | 20,580 | 19,364 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -77,271 | -71,480 | -105,421 | -100,890 | -95,963 |
| TOTAL | $41,250 | $46,239 | $11,877 | $14,595 | $17,272 |
| Total Liabilities And Equity | $45,404 | $48,992 | $14,568 | $17,899 | $20,485 |